2024 Avoca Industry Survey

The survey is now closed — thank you for your participation!

Avoca, a WCG company, takes pride in providing the industry with insights into trends in clinical research to optimize the execution and quality of clinical trials. This year, our survey focuses on potential changes in regulatory guidance under ICH E6 (R3). Importantly, you don’t need to be familiar with this draft guidance to participate – rather, we will provide information about anticipated changes and would like to understand your thoughts and reactions.

A report of aggregate findings and take-aways from the research is now available under Avoca’s Research Reports library.

RELATED CONTENT: